Dealing with grievances under new regulationsWith regulation, expected to come soon, techs will be held to the same standards pharmacists are accustomed to and will be accountable to the Ontario College of Pharmacists (OCP). Drug News: Finacea, FluMist, IntanzaFinacea: new topical treatment for rosacea; FluMist: first intranasal flu vaccine; Intanza: first intradermal flu vaccine. Clinical Notes: Canadian testicular cancer guidelines Guidelines developed on diagnosis, management of germ cell testicular cancer. Other opportunities enabling expanded scopes of practice Beyond the provision of prescriptive privileges. Medication Forum: SGLT2 inhibitors for type 2 diabetes The potential role of SGLT2 inhibitors in the management of type 2 diabetes. Editorial: How do you like your innovation? In these uncertain times, be open to new ideas, wherever they originate. Research Highlights: Drug-eluting stents - duration of dual antiplatelet therapy Percutaneous coronary intervention is a procedure used to treat the stenotic coronary arteries found in coronary heart disease. Abrupt Stop: Discontinuation syndrome Managing discontinuation syndrome associated with psychoactive medications. Celiac disease: the stealthy robber of health There are many myths and misconceptions surrounding celiac disease. Letter: Questioning the role of DPP-4 inhibitors A reader comments on the role of DPP-4 inhibitors in the management of type 2 diabetes. First Previous 3647 3648 3649 3650 3651 Next Last
